Indietro

Selezionare la regione

Azienda

Richiedi un consulto sulle cellule staminali

Per saperne di più

I nostri
trapianti

Elenco degli utilizzi delle cellule staminali approvati dai laboratori del gruppo FamiCord:

Immagine
Elenco degli utilizzi delle cellule staminali approvati dai laboratori del gruppo FamiCord:
Nr. Fonte Tipo di fonte Diagnosi Settore medico Anno di applicazione Terapia Paese Età del destinatario
801 Cord Tissue Allogeneic – Unrelated Autism Neurology 2025 Experimental Therapy Poland 15,2
802 Cord Tissue Allogeneic – Unrelated GvHD Immunology 2025 Experimental Therapy Poland 13
803 Cord Tissue Allogeneic – Unrelated Cartilage Lesions Orthopedics 2025 Experimental Therapy Poland 48,2
804 Cord Tissue Allogeneic – Unrelated Cartilage Lesions Orthopedics 2025 Experimental Therapy Poland 51,6
805 Cord Tissue Allogeneic – Unrelated GvHD Hematology 2025 Experimental Therapy Poland 12,9
806 Cord Tissue Allogeneic – Unrelated Autism Neurology 2025 Experimental Therapy Poland 10,1
807 Cord Tissue Allogeneic – Unrelated Autism Neurology 2025 Experimental Therapy Poland 8,4
808 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2025 Experimental Therapy Poland 3,7
809 Cord Tissue Allogeneic – Unrelated Cerebral Infarction Neurology 2025 Experimental Therapy Poland 57,8
810 Cord Tissue Allogeneic – Unrelated Autism Neurology 2025 Experimental Therapy Poland 7,7
811 Cord Tissue Allogeneic – Unrelated Cerebellar Syndrome Neurology 2025 Experimental Therapy Poland 43,4
812 Cord Tissue Allogeneic – Unrelated Cartilage Lesions Orthopedics 2025 Experimental Therapy Poland 61,1
813 Cord Tissue Allogeneic – Unrelated Cartilage Lesions Orthopedics 2025 Experimental Therapy Poland 57,9
814 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2025 Experimental Therapy Poland 1,2
815 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2025 Experimental Therapy Poland 7,1
816 Cord Tissue Allogeneic – Unrelated Autism Neurology 2025 Experimental Therapy Poland 3
817 Cord Blood Allogeneic – Related Thalassemia Major Hematology 2025 Standard Therapy Turkey 5,9
818 Cord Blood Autologous Aplastic Anemia Hematology 2025 Standard Therapy Poland 2
819 Cord Blood Allogeneic – Related Thalassemia Major Hematology 2025 Standard Therapy Turkey 6,8
820 Cord Blood Allogeneic – Related Cerebral Palsy Neurology 2025 Experimental Therapy Portugal 1 year and 8 months
821 Cord Blood Autologous Autism Neurology 2025 Experimental Therapy Romania 5
822 Cord Blood Allogeneic Acute lymphoblastic leukemia Hematology 2025 Standard Therapy Poland 13
823 Cord Blood Autologous Autism Neurology 2025 Experimental Therapy Poland 5 ,5
824 Cord Blood Autologous Autism Neurology 2025 Experimental Therapy Poland 7,2
825 Cord Blood Allogeneic Thalassemia Major Hematology 2025 Standard Therapy Turkey 10,9
826 Cord Blood Autologous Autism Neurology 2025 Experimental Therapy Poland 4,1
827 Cord Blood Autologous Cerebral Palsy Neurology 2025 Experimental Therapy Poland 3,1
828 Cord Blood Autologous Autism Neurology 2025 Experimental Therapy Poland 5,2
829 Cord Blood Autologous Autism Neurology 2025 Experimental Therapy Poland 2,11
830 Cord Blood Autologous Unbalanced AVSD Cardiovascular 2025 Experimental Therapy Poland 5 months
831 Cord Blood Allogeneic – Related Relapsed Lymphoblastic Leukemia Hematology 2025 Standard Therapy Turkey 8,5
832 Cord Blood Autologous Autism Neurology 2025 Experimental Therapy Poland 10,1
833 Cord Blood Autologous Autism Neurology 2025 Experimental Therapy Poland 5,7
834 Cord Blood Autologous Autism Neurology 2025 Experimental Therapy Poland 4,4
835 Cord Blood Autologous Autism Neurology 2025 Experimental Therapy Poland 5,5
836 Cord Blood Autologous Autism Neurology 2025 Experimental Therapy Poland 5,4
837 Cord Blood Autologous Autism Neurology 2025 Experimental Therapy Poland 3,9
838 Cord Blood Allogeneic – Related D57.1 Sickle Cell Anemia Hematology 2025 Standard Therapy Turkey 5 years 6 months
839 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy France 66
840 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 63
841 Bone Marrow Family Allogeneic Myelofibrosis Hematology 2025 Standard Therapy Poland 71
842 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy United Kingdom 72
843 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy France 47
844 Bone Marrow Family Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Ukraine 43
845 Bone Marrow Family Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Italy 49
846 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy France 51
847 Bone Marrow Family Allogeneic Philadelphia – positive Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Germany 61
848 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy France 58
849 Bone Marrow Family Allogeneic Myelofibrosis Hematology 2025 Standard Therapy NETHERLANDS 63
850 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 65
851 Bone Marrow Family Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy France 63
852 Bone Marrow Family Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Poland 68
853 Bone Marrow Family Allogeneic Myelofibrosis Hematology 2025 Standard Therapy France 71
854 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Russia 51
855 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 62
856 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Czechia 54
857 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy United Kingdom 16
858 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 61
859 Bone Marrow Family Allogeneic Chronic Myelomonocytic Leukemia Hematology 2025 Standard Therapy Poland 61
860 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Italy 70
861 Bone Marrow Family Allogeneic PostET Myelofibrosis Hematology 2025 Standard Therapy Netherlands 21
862 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 68
863 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia/ Mielodysplastic Syndrome Hematology 2025 Standard Therapy Germany 65
864 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy NETHERLANDS 60
865 Bone Marrow Family Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy USA 33
866 Bone Marrow Family Allogeneic Muscular Dystrophy Association Hematology 2025 Standard Therapy United Kingdom 75
867 Bone Marrow Family Allogeneic Acute Myeloid Leukemia Hematology 2025 Standard Therapy Germany 72
868 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 77
869 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy France 23
870 Bone Marrow Family Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Germany 58
871 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy United Kingdom 53
872 Bone Marrow Family Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Germany 75
873 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 61
874 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy France 8
875 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 63
876 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Ukraine 38
877 Bone Marrow Family Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Germany 70
878 Bone Marrow Family Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy USA 69
879 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy France 31
880 Bone Marrow Family Allogeneic Acute Myleogenous Leukemia, alloPBST 7/2025 Hematology 2025 Standard Therapy Germany 53
881 Bone Marrow Allogeneic Aplastic Anemia Hematology 2025 Standard Therapy Spain 15
882 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2025 Standard Therapy Norway 55
883 Bone Marrow Allogeneic Inherited Immune System Disorder Hematology 2025 Standard Therapy France 3
884 Bone Marrow Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy USA 7
885 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2025 Standard Therapy Ukraine 36
886 Bone Marrow Allogeneic Inherited Immune System Disorder Hematology 2025 Standard Therapy France 10
887 Bone Marrow Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy USA 76
888 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2025 Standard Therapy Poland 39
889 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy South Africa 6
890 Bone Marrow Allogeneic Wiskott-Aldrich syndrome Hematology 2025 Standard Therapy Turkey 6
891 Bone Marrow Allogeneic Combined immnunodeficiency Hematology 2025 Standard Therapy Ukraine 3 months
892 Bone Marrow Allogeneic Chronic Granulomatous Disease Hematology 2025 Standard Therapy Poland 3
893 Bone Marrow Allogeneic Mixed Phenotype Acute Leukemia Hematology 2025 Standard Therapy Poland 13
894 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2025 Standard Therapy Poland 7
895 Bone Marrow Allogeneic B-cell precursor Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Poland 56
896 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2025 Standard Therapy Poland 43
897 Bone Marrow Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Poland 19
898 Bone Marrow Allogeneic Very Severe Aplastic Anemia Hematology 2025 Standard Therapy Poland 12
899 Bone Marrow Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Poland 5
900 Bone Marrow Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Poland 10 months